Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Linvoseltamab |
Trade Name | |
Synonyms | REGN5458|REGN-5458|REGN 5458|Anti-BCMA/CD3 BiTE |
Drug Descriptions |
Linvoseltamab (REGN5458) is a bispecific antibody that binds to TNFRSF17 (BCMA) and CD3 with potential antitumor activity (Blood (2019) 134 (Supplement_1): 3176). |
DrugClasses | CD3 Antibody 99 TNFRSF17 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C158504 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bortezomib + Dexamethasone + Linvoseltamab | Bortezomib Dexamethasone Linvoseltamab | 0 | 1 |
Carfilzomib + Dexamethasone + Linvoseltamab | Carfilzomib Dexamethasone Linvoseltamab | 0 | 1 |
Daratumumab + Dexamethasone + Linvoseltamab | Daratumumab Dexamethasone Linvoseltamab | 0 | 1 |
Dexamethasone + Lenalidomide + Linvoseltamab | Dexamethasone Lenalidomide Linvoseltamab | 0 | 1 |
Linvoseltamab | Linvoseltamab | 0 | 6 |